Clinical trial
Minimizing Radiographic Contrast Administration During Coronary Angiography Using a Novel Contrast Reduction System: A Multicenter Observational Study of the DyeVert™ Plus Contrast Reduction System
NCT03715452 is registered in ClinicalTrials.gov with Osprey Medical, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minimizing Radiographic Contrast Administration During Coronary Angiography Using a Novel Contrast Reduction System: A Multicenter Observational Study of the DyeVert™ Plus Contrast Reduction System
- Lead sponsor
- Osprey Medical, Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2017
- Completion date
- March 30, 2018
- Enrollment
- 114 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease